These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2315977)

  • 1. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
    Guédeney X; Chanez C; Grenier A; Scherrmann JM
    Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Biochem; 1986 Aug; 19(4):201-4. PubMed ID: 3530526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivity of endogenous digitalis-like substances in cord blood sera studied with antidigitoxin monoclonal antibodies.
    Sandré C; Géniteau-Legendre M; Scherrmann JM; Quéro AM; Labarre C
    Ther Drug Monit; 1995 Feb; 17(1):19-24. PubMed ID: 7725372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors.
    Graves SW; Sharma K; Chandler AB
    Clin Chem; 1986 Aug; 32(8):1506-9. PubMed ID: 3755385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in apparent serum digitalis-like factor levels with different digoxin antibodies. The "immunochemical fingerprint".
    Naomi S; Graves S; Lazarus M; Williams GH; Hollenberg NK
    Am J Hypertens; 1991 Oct; 4(10 Pt 1):795-801. PubMed ID: 1747212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufalin radioimmunoassays: in search of the endogenous digitalis-like substance.
    Panesar NS
    J Immunoassay; 1994 Nov; 15(4):371-91. PubMed ID: 7836543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly specific radioimmunoassay for digoxin using a monoclonal antibody selected for lack of interference by digoxin-like immunoreactive substances in cord blood sera.
    Wahyono D; Piechaczyk M; Scherrmann JM; Girard C; Grenier J; Mani JC; Bastide JM; Pau B
    Ther Drug Monit; 1991 Mar; 13(2):113-9. PubMed ID: 2053117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification of endogenous digitalis-like compound(s) in cord blood.
    Balzan S; Ghione S; Biver P; Gazzetti P; Montali U
    Clin Chem; 1991 Feb; 37(2):277-81. PubMed ID: 1993339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay.
    Ijiri Y; Hayashi T; Kamegai H; Ohi K; Suzuki K; Kitaura Y; Takenaka H
    Ther Drug Monit; 2003 Apr; 25(2):234-9. PubMed ID: 12657920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 18. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like immunoreactive substances in the perinatal period.
    Seccombe DW; Pudek MR
    Lancet; 1987 Apr; 1(8539):983. PubMed ID: 2882377
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.